Beth Israel Deaconess Medical Center
Stem Cell Transplant Program
330 Brookline Avenue
Boston, MA 2215
Direct phone: (617) 667-9920
Total transplants by cell source
- Marrow: 3
- PBSC: 44
- Cord Blood: 0
- Autologous (PBSC or Marrow): 56
About the center
The BMT Program started in 1983 with autologous transplants. It expanded in 1999 with related allogeneic, matched unrelated in 2001, and cords in 2007. Received FACT accreditation in 2001 and has been re-accredited in 2004, 2007,2010, 2013,2016, and 2019. In 2011, program expanded to include patients with HIV. Involved in radioimmunotherapy and tumor immunotherapy research. Has developed translational laboratory pre-clinical models for cancer vaccines, CAR T cells, novel combinatorial strategies, targeted therapies for T cell lymphoma, thrombosis and cancer.
This center has been performing allogeneic transplants since 1999 and has been an NMDP/Be The Match transplant center since January 2002.
Adult - Jon Arnason, David Avigan, Vassiliki Boussiotis, Brian Carney, Ajoy Dias, Jason Freed, Robin M. Joyce, Michael Leukam, Jessica Liegel, Rushad Patell, Jacalyn Rosenblatt, David Sermer M.D., Juan Varela, Gottfried von Keudell, Matthew Weinstock
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
BIDMC Social Work Department has 3 furnished apartments for $400 week at The Veridean on Boylston St in Boston, MA. Additionally, housing is available at Hope Lodge a program of the American Cancer Society, 125 Huntington Ave, Boston, MA.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 61 patients.
The actual 1-year survival of these patients is 77.0%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66.2% and 86.7%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Denise Cummings (Hurley)
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
No survivorship program information is available. Contact the center for information about post-transplant care.